Sledovať
Michelle Whirl-Carrillo
Michelle Whirl-Carrillo
Overená e-mailová adresa na: stanford.edu
Názov
Citované v
Citované v
Rok
Pharmacogenomics knowledge for personalized medicine
M Whirl‐Carrillo, EM McDonagh, JM Hebert, L Gong, K Sangkuhl, ...
Clinical Pharmacology & Therapeutics 92 (4), 414-417, 2012
20582012
Personal omics profiling reveals dynamic molecular and medical phenotypes
R Chen, GI Mias, J Li-Pook-Than, L Jiang, HYK Lam, R Chen, E Miriami, ...
Cell 148 (6), 1293-1307, 2012
13802012
Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update.
MV Relling, EE Gardner, WJ Sandborn, K Schmiegelow, CH Pui, SW Tee, ...
Clinical Pharmacology and Therapeutics 93 (4), 324-5, 2013
8772013
Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing
MV Relling, EE Gardner, WJ Sandborn, K Schmiegelow, CH Pui, SW Tee, ...
Clinical Pharmacology and Therapeutics 89 (2), 387-91, 2011
8772011
The BioPAX community standard for pathway data sharing
E Demir, MP Cary, S Paley, K Fukuda, C Lemer, I Vastrik, G Wu, ...
Nature biotechnology 28 (9), 935-942, 2010
7892010
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing
JA Johnson, L Gong, M Whirl‐Carrillo, BF Gage, SA Scott, CM Stein, ...
Clinical Pharmacology & Therapeutics 90 (4), 625-629, 2011
7672011
Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for pharmacogenetics‐guided warfarin dosing: 2017 update
JA Johnson, KE Caudle, L Gong, M Whirl‐Carrillo, CM Stein, SA Scott, ...
Clinical Pharmacology & Therapeutics 102 (3), 397-404, 2017
6152017
Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update
MV Relling, M Schwab, M Whirl‐Carrillo, G Suarez‐Kurtz, CH Pui, ...
Clinical Pharmacology & Therapeutics 105 (5), 1095-1105, 2019
5362019
Clinical interpretation and implications of whole-genome sequencing
FE Dewey, ME Grove, C Pan, BA Goldstein, JA Bernstein, H Chaib, ...
Jama 311 (10), 1035-1045, 2014
5172014
Prediction of CYP2D6 phenotype from genotype across world populations
A Gaedigk, K Sangkuhl, M Whirl-Carrillo, T Klein, JS Leeder
Genetics in Medicine 19 (1), 69-76, 2017
4892017
Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)
KE Caudle, HM Dunnenberger, RR Freimuth, JF Peterson, JD Burlison, ...
Genetics in Medicine 19 (2), 215-223, 2017
4832017
Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process
K E Caudle, T E Klein, J M Hoffman, D J Muller, M Whirl-Carrillo, L Gong, ...
Current drug metabolism 15 (2), 209-217, 2014
4402014
Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and …
KE Caudle, K Sangkuhl, M Whirl‐Carrillo, JJ Swen, CE Haidar, TE Klein, ...
Clinical and translational science 13 (1), 116-124, 2020
4372020
An evidence‐based framework for evaluating pharmacogenomics knowledge for personalized medicine
M Whirl‐Carrillo, R Huddart, L Gong, K Sangkuhl, CF Thorn, R Whaley, ...
Clinical Pharmacology & Therapeutics 110 (3), 563-572, 2021
3902021
The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database
A Gaedigk, M Ingelman‐Sundberg, NA Miller, JS Leeder, M Whirl‐Carrillo, ...
Clinical Pharmacology & Therapeutics 103 (3), 399-401, 2018
3872018
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy
MP Goetz, K Sangkuhl, HJ Guchelaar, M Schwab, M Province, ...
Clinical Pharmacology & Therapeutics 103 (5), 770-777, 2018
3042018
Cytochrome P450 2C9-CYP2C9
D Van Booven, S Marsh, H McLeod, MW Carrillo, K Sangkuhl, TE Klein, ...
Pharmacogenetics and genomics 20 (4), 277-281, 2010
2992010
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and HLA‐B Genotypes and Phenytoin Dosing
KE Caudle, AE Rettie, M Whirl‐Carrillo, LH Smith, S Mintzer, MTM Lee, ...
Clinical Pharmacology & Therapeutics 96 (5), 542-548, 2014
2732014
Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA‐B Genotype and Carbamazepine Dosing
SG Leckband, JR Kelsoe, HM Dunnenberger, AL George Jr, E Tran, ...
Clinical Pharmacology & Therapeutics 94 (3), 324-328, 2013
2622013
Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update
EJ Phillips, C Sukasem, M Whirl‐Carrillo, DJ Müller, HM Dunnenberger, ...
Clinical Pharmacology & Therapeutics 103 (4), 574-581, 2018
2592018
Systém momentálne nemôže vykonať operáciu. Skúste to neskôr.
Články 1–20